ABSTRACT
Interface engineering is one of the promising strategies for the long-term stabilization of perovskite solar cells (PSCs), preventing chemical decomposition induced by external agents and promoting fast charge transfer. Recently, MXenes-2D structured transition metal carbides and nitrides with various functionalization (O, -F, -OH) have demonstrated high potential for mastering the work function in halide perovskite absorbers and have significantly improved the n-type charge collection in solar cells. This work demonstrates that MXenes allow for efficient stabilization of PSCs besides improving their performances. A mixed composite bathocuproine:MXene, that is, (BCP:MXene) interlayer, is introduced at the interface between an electron-transport layer (ETL) and a metal cathode in the p-i-n device structure. The investigation demonstrates that the use of BCP:MXene interlayer slightly increases the power conversation efficiency (PCE) for PSCs (from 16.5 for reference to 17.5%) but dramatically improves the out of Glove-Box stability. Under ISOS-L-2 light soaking stress at 63 ± 1.5 °C, the T80 (time needed to reduce efficiency down to 80% of the initial one) period increases from 460 to > 2300 hours (h).
ABSTRACT
Six series of semisynthetic lipophilic glycopeptide antibiotic derivatives were evaluated for in vitro activity against influenza A and B viruses. The new teicoplanin pseudoaglycon-derived lipoglycopeptides were prepared by coupling one or two side chains to the N-terminus of the glycopeptide core, using various conjugation methods. Three series of derivatives bearing two lipophilic groups were synthesized by attaching bis-alkylthio maleimides directly or through linkers of different lengths to the glycopeptide. Access to the fourth and fifth series of compounds was achieved by click chemistry, introducing single alkyl/aryl chains directly or through a tetraethylene glycol linker to the same position. A sixth group of semisynthetic derivatives was obtained by sulfonylation of the N-terminus. Of the 42 lipophilic teicoplanin pseudoaglycon derivatives tested, about half showed broad activity against influenza A and B viruses, with some of them having reasonable or no cytotoxicity. Minor differences in the side chain length as well as lipophilicity appeared to have significant impact on antiviral activity and cytotoxicity. Several lipoglycopeptides were also found to be active against human coronavirus.